Cointime

Download App
iOS & Android

X4 Pharmaceuticals

company
Funding Round
Post-IPO Equity
Money Raised
$ 55M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
Abingworth - - - Detail
Altium Capital - - - Detail
Bain Capital Life Sciences - - - Detail
Driehaus Capital Management - - - Detail
Ikarian Capital - - - Detail
Lincoln Park Capital Fund - - - Detail
Monashee Investment Management - - - Detail
OrbiMed - - - Detail
Sio Capital Management - - - Detail

Historical Financing

Announced Date Round Money Raised Investors
Nov 16, 2017 Series A 0 Thynk Capital, LLC. Detail
Nov 16, 2017 Series B $ 27M Cormorant Asset Management Detail
Dec 15, 2015 Series A $ 37.49M Cormorant Asset Management Detail
Jan 1, 2014 Seed 0 SV Health Investors Detail
Nov 17, 2017 IPO 0 Detail